REQUEST A DEMO
Total
USD $0.00
Search more companies

Afflatus Pharmaceuticals Private Limited (India)

Main Activities: Other Services (except Public Administration)
Full name: Afflatus Pharmaceuticals Private Limited Profile Updated: May 18, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Afflatus Pharmaceuticals Private Limited is an unlisted company, incorporated on 08/09/2005. It has its registered office in the State of Delhi, India. Company's corporate identification number (CIN) is U00304DL2005PTC140510 and registration number is 140510. The company is a manufacturing company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Legal Address
E-29 Amar Colonylajpat Nagar Iv New Dldehi
South Delhi; Delhi; Postal Code: 110024

Contact Details: Purchase the Afflatus Pharmaceuticals Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Afflatus Pharmaceuticals Private Limited report to view the information.
Outstanding Shares:
Purchase the Afflatus Pharmaceuticals Private Limited report to view the information.
Registered Capital:
Purchase the Afflatus Pharmaceuticals Private Limited report to view the information.
Incorporation Date:
September 08, 2005
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Afflatus Pharmaceuticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
42.26%
Total operating revenue
42.27%
Operating profit (EBIT)
-194.24%
EBITDA
34.13%
Net Profit (Loss) for the Period
-144.82%
Total assets
35.27%
Total equity
-27.42%
Operating Profit Margin (ROS)
-2.05%
Net Profit Margin
-1.59%
Return on Equity (ROE)
-26.58%
Debt to Equity Ratio
138.45%
Quick Ratio
0.05%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?